189 related articles for article (PubMed ID: 1637675)
1. Role of cholecystokinin in dietary fat-promoted azaserine-induced pancreatic carcinogenesis in rats.
Appel MJ; Meijers M; Van Garderen-Hoetmer A; Lamers CB; Rovati LC; Sprij-Mooij D; Jansen JB; Woutersen RA
Br J Cancer; 1992 Jul; 66(1):46-50. PubMed ID: 1637675
[TBL] [Abstract][Full Text] [Related]
2. Effects of cholecystokinin and bombesin on development of azaserine-induced pancreatic tumours in rats: modulation by the cholecystokinin receptor antagonist lorglumide.
Meijers M; Appel MJ; van Garderen-Hoetmer A; Lamers CB; Rovati LC; Jansen JB; Woutersen RA
Carcinogenesis; 1992 Sep; 13(9):1525-8. PubMed ID: 1394835
[TBL] [Abstract][Full Text] [Related]
3. Effects of dietary fats and soybean protein on azaserine-induced pancreatic carcinogenesis and plasma cholecystokinin in the rat.
Roebuck BD; Kaplita PV; Edwards BR; Praissman M
Cancer Res; 1987 Mar; 47(5):1333-8. PubMed ID: 3815341
[TBL] [Abstract][Full Text] [Related]
4. Modulation by CR-1409 (lorglumide), a cholecystokinin receptor antagonist, of trypsin inhibitor-enhanced growth of azaserine-induced putative preneoplastic lesions in rat pancreas.
Douglas BR; Woutersen RA; Jansen JB; de Jong AJ; Rovati LC; Lamers CB
Cancer Res; 1989 May; 49(9):2438-41. PubMed ID: 2706631
[TBL] [Abstract][Full Text] [Related]
5. Stimulation of growth of azaserine-induced putative preneoplastic lesions in rat pancreas is mediated specifically by way of cholecystokinin-A receptors.
Povoski SP; Zhou W; Longnecker DS; Roebuck BD; Bell RH
Cancer Res; 1993 Sep; 53(17):3925-9. PubMed ID: 8358719
[TBL] [Abstract][Full Text] [Related]
6. Azaserine-induced pancreatic carcinogenesis in rats: promotion by a diet rich in saturated fat and inhibition by a standard laboratory chow.
Appel MJ; nan Garderen-Hoetmer A; Woutersen RA
Cancer Lett; 1990 Dec; 55(3):239-48. PubMed ID: 2257542
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor-alpha and epidermal growth factor expression in the exocrine pancreas of azaserine-treated rats: modulation by cholecystokinin or a low fat, high fiber (caloric restricted) diet.
Visser CJ; Woutersen RA; Bruggink AH; van Garderen-Hoetmer A; Seifert-Bock I; Tilanus MG; de Weger RA
Carcinogenesis; 1995 Sep; 16(9):2075-82. PubMed ID: 7554057
[TBL] [Abstract][Full Text] [Related]
8. Influence of cholecystokinin antagonist on the effects of cholecystokinin and bombesin on azaserine-induced lesions in rat pancreas.
Douglas BR; Woutersen RA; Jansen JB; de Jong AJ; Rovati LC; Lamers CB
Gastroenterology; 1989 Feb; 96(2 Pt 1):462-9. PubMed ID: 2910761
[TBL] [Abstract][Full Text] [Related]
9. Effects of dietary galactooligosaccharide on azaserine-induced acinar pancreatic carcinogenesis in male Wistar rats.
Appel MJ; Wijnands MV; Woutersen RA
Nutr Cancer; 1997; 29(1):35-41. PubMed ID: 9383782
[TBL] [Abstract][Full Text] [Related]
10. Modulation of growth and cell turnover of preneoplastic lesions and of prostaglandin levels in rat pancreas by dietary fish oil.
Appel MJ; Woutersen RA
Carcinogenesis; 1994 Oct; 15(10):2107-12. PubMed ID: 7955040
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effect of a cholecystokinin antagonist on pancreatic carcinogenesis after pancreatobiliary diversion.
Watanapa P; Flaks B; Oztas H; Deprez PH; Calam J; Williamson RC
Br J Cancer; 1993 Apr; 67(4):663-7. PubMed ID: 8471422
[TBL] [Abstract][Full Text] [Related]
12. Dietary fish oil (MaxEPA) enhances pancreatic carcinogenesis in azaserine-treated rats.
Appel MJ; Woutersen RA
Br J Cancer; 1996 Jan; 73(1):36-43. PubMed ID: 8554980
[TBL] [Abstract][Full Text] [Related]
13. Effect of cholecystokinin analogue caerulein and cholecystokinin antagonist lorglumide on pancreatic carcinogenesis in the rat.
Sperti C; Militello C; Rovati L; Behboo R; Khajeturian E; Perasole A; Alaggio R; Pedrazzoli S
J Surg Oncol; 1994 Sep; 57(1):11-6. PubMed ID: 8065144
[TBL] [Abstract][Full Text] [Related]
14. Effect of lorglumide (CR-1409) on pancreatic secretory and trophic response to caerulein in newborn rats.
Papp M; Varga G; Folly G
Acta Physiol Hung; 1991; 78(1):61-7. PubMed ID: 1722380
[TBL] [Abstract][Full Text] [Related]
15. Modulation of dietary fat-promoted pancreatic carcinogenesis in rats and hamsters by chronic coffee ingestion.
Woutersen RA; van Garderen-Hoetmer A; Bax J; Scherer E
Carcinogenesis; 1989 Feb; 10(2):311-6. PubMed ID: 2643485
[TBL] [Abstract][Full Text] [Related]
16. Gastrin receptor expression during azaserine-induced rat pancreatic carcinogenesis.
Tsuei BJ; Povoski SP; Zhou W; Bell RH
J Surg Res; 1996 Jun; 63(1):105-9. PubMed ID: 8661181
[TBL] [Abstract][Full Text] [Related]
17. Effects of high levels of dietary fats on the growth of azaserine-induced foci in the rat pancreas.
Roebuck BD
Lipids; 1986 Apr; 21(4):281-4. PubMed ID: 3487020
[TBL] [Abstract][Full Text] [Related]
18. Enhancing effect of partial gastrectomy on pancreatic carcinogenesis.
Watanapa P; Flaks B; Oztas H; Deprez PH; Calam J; Williamson RC
Br J Cancer; 1992 Mar; 65(3):383-7. PubMed ID: 1558791
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic secretory and trophic response to caerulein in rats: effect of proglumide and lorglumide.
Varga G; Papp M; Scarpignato C
Fundam Clin Pharmacol; 1989; 3(3):295-306. PubMed ID: 2475419
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of the growth of azaserine-induced nodules in the rat pancreas by dietary camostate (FOY-305).
Lhoste EF; Roebuck BD; Longnecker DS
Carcinogenesis; 1988 Jun; 9(6):901-6. PubMed ID: 3259478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
